Related Experiment Video
Updated: Feb 18, 2026
06:02
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
7.5K
Host target-based approaches against arboviral diseases
Rebeca Froes Rocha1,2, Juliana Lemos Del Sarto1,2, Rafael Elias Marques3
1Departament of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil.
Biological Chemistry
|November 18, 2017
Summary
Mosquito-borne viral diseases like dengue, chikungunya, and Zika are increasing globally. Host-targeted therapies offer a promising alternative to traditional antiviral drugs, which have limitations.
Area of Science:
- * Arbovirology and infectious disease epidemiology.
- * Molecular virology and immunology.
- * Vector-borne disease control and public health.
Background:
- * Socioeconomic and environmental changes have led to the resurgence of mosquito-borne viral diseases globally.
- * Arboviruses, including dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV), represent a significant and growing threat, accounting for approximately 30% of emerging vector-borne diseases.
- * Current therapeutic strategies often target the virus directly but face challenges such as limited effectiveness, drug resistance, and side effects.
Purpose of the Study:
- * To explore the potential of host-targeted therapies for managing arboviral infections.
- * To highlight the limitations of current antiviral treatments.
- * To emphasize the need for understanding host immune responses in arboviral disease pathogenesis.
Main Methods:
- * Review of existing literature on arboviral diseases and therapeutic strategies.
- * Analysis of the mechanisms of action for both virus-targeted and host-targeted therapies.
- * Discussion of the immunological factors contributing to disease severity.
Main Results:
- * Virus-targeted therapies are effective but limited by resistance, side effects, and narrow therapeutic windows.
- * Host-targeted therapies present an alternative by modulating the immune response, potentially overcoming limitations of direct antiviral agents.
- * Understanding host immune patterns is crucial for developing effective host-targeted treatments for DENV, CHIKV, and ZIKV.
Conclusions:
- * Host-targeted therapies are a viable and important strategy for combating arboviral diseases.
- * Further research into host immune responses is essential for optimizing these therapies.
- * Combined therapeutic approaches may offer enhanced efficacy against mosquito-borne viral infections.
